Secondary prophylaxis of hepatic encephalopathy in cirrhosis: A double blind randomized controlled trial of L-ornithine L-aspartate versus placebo

被引：0
|
作者：
Varakanahalli, S. [1 ]
Sharma, B. [1 ]
Sachdeva, S. [1 ]
Dahale, A. [1 ]
Srivastava, S. [1 ]
机构：
[1] GB Pant Inst Postgrad Med Educ & Res, Gastroenterol, New Delhi, India
来源：
JOURNAL OF HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
10.1016/S0168-8278(18)30304-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PS-074
引用
收藏
页码：S43 / S43
页数：1
相关论文
共 50 条
  • [41] ORAL L-ORNITHINE-L-ASPARTATE (LOLA) FOR PATIENTS WITH OVERT HEPATIC ENCEPHALOPATHY TREATED WITH LACTULOSE; A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED TRIAL
    Nimanong, S.
    Siwaporn, C.
    Sansak, I.
    Tanwandee, T.
    Charatcharoenwitthaya, P.
    Chotiyaputta, W.
    Boonyapisit, K.
    Pausawasdi, N.
    Prachayakul, W.
    Pongprasobchai, S.
    Leelakusolvong, S.
    Manatsathit, S.
    Kachintorn, U.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S78 - S78
  • [42] FUNCTIONAL CORE MODULATION FOLLOWING TREATMENT OF MINIMAL HEPATIC ENCEPHALOPATHY WITH L-ORNITHINE L-ASPARTATE: A POTENTIAL NOVEL MECHANISM OF ACTION
    McPhail, M. J.
    Leech, R.
    Grover, V. P.
    Fitzpatrick, J.
    Dhanjal, N. S.
    Saxby, B. K.
    Wesnes, K.
    Thomas, H. C.
    Wise, R. J.
    Taylor-Robinson, S. D.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S74 - S75
  • [43] Effect of l-ornithine l-aspartate against thioacetamide-induced hepatic damage in rats
    Najmi, Abul K.
    Pillai, K. K.
    Pal, S. N.
    Akhtar, M.
    Aqil, M.
    Sharma, M.
    INDIAN JOURNAL OF PHARMACOLOGY, 2010, 42 (06) : 384 - 387
  • [44] Secondary Prophylaxis of Hepatic Encephalopathy: An Open Label Randomized Controlled Trial of Lactulose Versus Placebo
    Sharma, Praveen
    Sharma, Barjesh
    Agarwal, Amit
    Sarin, Shiv
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S149 - S149
  • [45] A randomized, double-blind and placebo-controlled crossover trial on the effect of L-ornithine ingestion on the human circadian dock
    Fukuda, Takafumi
    Haraguchi, Atsushi
    Takahashi, Masaki
    Nakaoka, Takashi
    Fukazawa, Mayuko
    Okubo, Jin
    Ozaki, Mamiho
    Kanatome, Ayana
    Ohya, Rena
    Miura, Yutaka
    Obara, Kuniaki
    Shibata, Shigenobu
    CHRONOBIOLOGY INTERNATIONAL, 2018, 35 (10) : 1445 - 1455
  • [46] Clinical Efficacy of L-Ornithine L-Aspartate in the Prevenction of Altered Oral Glutamine Challenge in Patients With Minimal Hepatic Encephalopathy: A Pilot Study
    Maldonado, Hector J.
    Torres, Juan Obed Gaytan
    Vazquez-Elizondo, Genaro
    Sandoval, Martha G. Cardenas
    Garza-Gonzalez, Elvira
    Bosques, Francisco J.
    GASTROENTEROLOGY, 2010, 138 (05) : S818 - S818
  • [47] Secondary Prophylaxis of Hepatic Encephalopathy: An Open-Label Randomized Controlled Trial of Lactulose Versus Placebo
    Sharma, Barjesh Chander
    Sharma, Praveen
    Agrawal, Amit
    Sarin, Shiv Kumar
    GASTROENTEROLOGY, 2009, 137 (03) : 885 - 891
  • [48] Secondary prophylaxis of hepatic encephalopathy: an open label, pilot, randomized controlled trial of lactulose versus placebo
    Sharma, P.
    Tyagi, P.
    Sarin, S. K.
    Sharma, B. C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A76 - A76
  • [49] L-ornithine aspartate among cirrhotic patients with hepatic encephalopathy: does it make a difference?
    Tan-Pilar, Lleza
    Mercado, Randy
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A41 - A41
  • [50] Intravenous versus oral 'l-ornithine-l-aspartate' in overt hepatic encephalopathy: a randomized comparative study
    Jhajharia, Ashok
    Singh, Shashank
    Jana, Sangeeta
    Ashdhir, Prachis
    Nijhawan, Sandeep
    SCIENTIFIC REPORTS, 2024, 14 (01):
12345